JP2001519346A5 - - Google Patents

Download PDF

Info

Publication number
JP2001519346A5
JP2001519346A5 JP2000514908A JP2000514908A JP2001519346A5 JP 2001519346 A5 JP2001519346 A5 JP 2001519346A5 JP 2000514908 A JP2000514908 A JP 2000514908A JP 2000514908 A JP2000514908 A JP 2000514908A JP 2001519346 A5 JP2001519346 A5 JP 2001519346A5
Authority
JP
Japan
Prior art keywords
triazol
phenyl
wide
medium
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000514908A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001519346A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/020476 external-priority patent/WO1999018097A1/en
Publication of JP2001519346A publication Critical patent/JP2001519346A/ja
Publication of JP2001519346A5 publication Critical patent/JP2001519346A5/ja
Withdrawn legal-status Critical Current

Links

JP2000514908A 1997-10-07 1998-10-05 抗真菌性結晶性多形物 Withdrawn JP2001519346A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94618397A 1997-10-07 1997-10-07
US08/946,183 1997-10-07
PCT/US1998/020476 WO1999018097A1 (en) 1997-10-07 1998-10-05 Crystalline antifungal polymorph

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008000110A Division JP2008106075A (ja) 1997-10-07 2008-01-04 抗真菌性結晶性多形物

Publications (2)

Publication Number Publication Date
JP2001519346A JP2001519346A (ja) 2001-10-23
JP2001519346A5 true JP2001519346A5 (enExample) 2005-09-02

Family

ID=25484068

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2000514908A Withdrawn JP2001519346A (ja) 1997-10-07 1998-10-05 抗真菌性結晶性多形物
JP2008000110A Withdrawn JP2008106075A (ja) 1997-10-07 2008-01-04 抗真菌性結晶性多形物
JP2012114724A Pending JP2012153729A (ja) 1997-10-07 2012-05-18 抗真菌性結晶性多形物
JP2012114725A Pending JP2012153730A (ja) 1997-10-07 2012-05-18 抗真菌性結晶性多形物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2008000110A Withdrawn JP2008106075A (ja) 1997-10-07 2008-01-04 抗真菌性結晶性多形物
JP2012114724A Pending JP2012153729A (ja) 1997-10-07 2012-05-18 抗真菌性結晶性多形物
JP2012114725A Pending JP2012153730A (ja) 1997-10-07 2012-05-18 抗真菌性結晶性多形物

Country Status (30)

Country Link
EP (1) EP1021439B1 (enExample)
JP (4) JP2001519346A (enExample)
KR (1) KR100626109B1 (enExample)
CN (1) CN1125067C (enExample)
AR (1) AR015947A1 (enExample)
AT (1) ATE263163T1 (enExample)
AU (1) AU759982B2 (enExample)
BR (1) BR9812866A (enExample)
CA (1) CA2305803C (enExample)
CO (1) CO4970829A1 (enExample)
CZ (1) CZ299835B6 (enExample)
DE (1) DE69822859T2 (enExample)
DK (1) DK1021439T3 (enExample)
ES (1) ES2217594T3 (enExample)
HU (1) HU225233B1 (enExample)
ID (1) ID29290A (enExample)
IL (1) IL135331A (enExample)
IN (1) IN1998CH02232A (enExample)
MX (1) MX225999B (enExample)
MY (1) MY130126A (enExample)
NO (1) NO318827B1 (enExample)
NZ (1) NZ503662A (enExample)
PE (1) PE120499A1 (enExample)
PH (1) PH11998002606B1 (enExample)
PL (1) PL189317B1 (enExample)
PT (1) PT1021439E (enExample)
SK (1) SK285190B6 (enExample)
TW (1) TW589310B (enExample)
WO (1) WO1999018097A1 (enExample)
ZA (1) ZA989063B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
EP2451805A1 (en) 2009-07-09 2012-05-16 Sandoz AG A crystalline form of posaconazole
WO2011144656A1 (en) 2010-05-19 2011-11-24 Sandoz Ag Preparation of posaconazole intermediates
CA2798010C (en) 2010-05-19 2018-09-25 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
WO2011144655A1 (en) 2010-05-19 2011-11-24 Sandoz Ag Process for the preparation of chiral hydrazides
RU2585760C2 (ru) * 2010-05-19 2016-06-10 Сандоз Аг Способ получения хиральных триазолонов
CN108329303A (zh) 2011-06-16 2018-07-27 桑多斯股份公司 制备手性化合物的方法
EP2758385B1 (en) * 2011-09-19 2018-03-28 MSN Laboratories Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
CN105579448B (zh) * 2013-07-25 2018-12-21 桑多斯股份公司 制备泊沙康唑的晶型iv的改进方法
ITMI20132118A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132115A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132114A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132117A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
CN104387374A (zh) * 2014-10-21 2015-03-04 江苏恒盛药业有限公司 泊沙康唑晶型i的制备工艺
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
LT3209647T (lt) 2014-10-21 2020-09-25 Ariad Pharmaceuticals, Inc. Kristalinės 5-chlor-n4-[-2-(dimetilfosforil)fenil]-n2-{2-metoksi-4-[4-(4-metilpiperazin-1-il) piperidin-1-il]pirimidin-2,4-diamino formos
EP3590505B1 (en) 2015-08-08 2024-11-06 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole
EA039213B1 (ru) 2015-12-24 2021-12-17 Такеда Фармасьютикал Компани Лимитед Сокристалл, способ его получения и лекарственное средство, содержащее сокристалл
EP4424308A3 (en) 2016-02-26 2024-12-04 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
TR201722493A2 (tr) 2017-12-28 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
WO2022034232A1 (en) 2020-08-13 2022-02-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant high-strength formulation containing posaconazole
WO2023012378A1 (en) 2021-11-25 2023-02-09 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
AU681753B2 (en) * 1993-12-21 1997-09-04 Merck Sharp & Dohme Corp. Tetrahydrofuran antifungals
PT741737E (pt) * 1994-01-24 2000-04-28 Janssen Pharmaceutica Nv Antifungicos do tipo azole soluveis em agua
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
IL118464A (en) * 1995-06-02 2000-08-13 Schering Corp (2R-cis)-4-¬4-¬4-¬4¬¬-5-(2',4 dihalophenyl)-tetrahydro-5-(1-H-1,2,4,triazol-1-yl-methyl)furan-3-yl(methoxy¾phenyl¾-1-piperazinyl¬phenyl2,4,dihydro2¬(5)-1-ethyl-2-(5)hydroxy propyl¾-3H-1,2,4-triazol-3-one and pharmaceutical compositions comprising them

Similar Documents

Publication Publication Date Title
JP2001519346A5 (enExample)
NZ503662A (en) Crystalline polymorph of (-)-4-[4-[4-[4-[[(2R-cis)-5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)furan-3-yl]-methoxy]phenyl]-1-piperazinyl]phenyl-2,4-dihydro-2-[(S)-1-ethyl-2(S)-hydroxylpropyl]-3H-1,2,4-triazol-3-one and its use as a fungicide
RU98116435A (ru) Производные триазола, используемые в терапии
JP2004520292A5 (enExample)
JP3210017B2 (ja) 三置換テトラヒドロフラン抗真菌化合物
KR960704884A (ko) 항종양제 또는 항바이러스제로서의 디스타마이신 A 동족체 (Distamycin A analogues as antitumour or antiviral agents)
JP2002541109A5 (enExample)
NO986087L (no) Oralt preparat omfattende en antifungal triazolforbindelse
KR910021398A (ko) 트리아졸 항진균제
JP2001526218A5 (enExample)
JP2004523535A5 (enExample)
CA2388320A1 (en) N-substituted carbamoyloxyalkyl-azolium derivatives
KR890006593A (ko) 아르마타제 억제4(5)- 이미다졸
DE3684431D1 (de) Derivate des ((4-(4-(4-phenyl-1-piperazinyl)phenoxymethyl)-1,3-dioxolan-2yl)methyl)-1h-imidazol und 1h-1,2,4-triazol.
JP2007500160A5 (enExample)
CA2371012A1 (en) 4-(1h-pyrrol-1-yl) imidazoles
RU97108168A (ru) Ингибиторы синтеза аполипопротеина-в
HUT50333A (en) Process for producing pharmaceutical compositions comprising 1h-imidazoles and 1h-1,2,4-triazoles as active ingredient and process for producing the active ingredients
JP2004520424A5 (enExample)
RU97115290A (ru) Соединения азола, способ получения указанных соединений и их применение
NZ233502A (en) 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions
RU2006139644A (ru) Новые растворимые в воде пролекарства
IL70718A (en) 2-phenyl-1-(imidazo-2-yl or 1,2,4-triazol-3-yl or tetrazol-5-yl)-3-(1h-1,2,4-triazol-1-yl)propan-2-ol derivatives,their preparation and pharmaceutical compositions containing them
JP2003509494A5 (enExample)
JP2002535360A5 (enExample)